Concepedia
Statistics
Publications
21
Citations
754
H-Index
17
Active since
2008
Affiliations
Seoul National University(Current)
Seoul National University Hospital
Seoul National University Bundang Hospital
Cancer Research Institute
Korea Advanced Institute of Science and Technology
Seongyeong Kim is an author at Seoul National University specializing in oncology, molecular oncology, and medicine.
Publications per year
2008–2025
AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells
Ahrum Min, Seock‐Ah Im, Hyemin Jang et al. · Molecular Cancer Therapeutics · 2017 · 147 citations
Life Sciences, Oncology, Pharmacology +17
Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells
Ahrum Min, Jung Eun Kim, Yu‐Jin Kim et al. · Cancer Letters · 2018 · 93 citations
Medicine, Oncology, Pharmacology +16
Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer
Dong-Hyeon Ha, Ahrum Min, Seongyeong Kim et al. · Scientific Reports · 2020 · 82 citations · Full text
Life Sciences, Cancer Biology, Oncology +17
Anti‐tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells
Hee‐Jun Kim, Ahrum Min, Seock‐Ah Im et al. · International Journal of Cancer · 2016 · 63 citations · Full text
Medicine, Cancer Biology, Pharmacology +16
The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab
Jung Won Shin, Soohyun Kim, Suji Ha et al. · Biomolecules · 2019 · 31 citations · Full text
Medicine, Cancer Biology, Oncology +13
1–5 of 21